ABOUT HIARY

Let's connect


Learn how Hiray Pharma shares their proprietary technology with you.

Registration

05

2023

-

09

Public Notice of Environmental Protection Acceptance of Project 103 of Hiray Pharmaceutical (Jingmen) Co.

Category:

Main news


According to the Decision of the State Council on Amending the Regulations on the Administration of Environmental Protection on the Completion of Construction Projects (State Council Decree No. 682), and the Announcement of the Ministry of Environmental Protection on Issuing Interim Measures for the Acceptance of Environmental Protection on the Completion of Construction Projects (State Environmental Protection Regulation on Environmental Assessment [2017] No. 4), the annual production capacity of the project of 70 tonnes of antiviral protease inhibitor raw materials and its key intermediates of Hiray Pharmaceutical (Jingmen) Co. The completion of environmental protection acceptance is announced as follows:

Project name: Annual output of 70 tonnes of antiviral protease inhibitor API and its key intermediates project of Hiray Pharmaceutical (Jingmen) Co.

Construction Location: No.1 Xinghua 3rd Road, Duodao District, Jingmen City, Hubei Province, China

Construction unit: Hiray Pharmaceutical (Jingmen) Co.

Publication content: acceptance monitoring report, acceptance opinion, other need to explain the situation see link.

Link: https://pan.baidu.com/s/1VxxoX44exnR9TzhgU7pxQQ

Extract code: hj0m

Publicity time: 22 August 2022 - 18 September 2022 (twenty working days)

During the period of publicity, if you have any objections to the above, please provide feedback in writing, individuals must sign their real names, and the unit must be stamped with an official seal

Contact: Ms Tian

Contact Tel: 187-6122-2657